Deaconess Clinic   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Evansville IN United States (2008)

Organization Overview

First Clinical Trial
2008
NCT00701779
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Deaconess Clinic, Inc. | Deaconess Clinic Research Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Hyperplasia (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Prostatic Hyperplasia (Phase 4)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6